Chemical Compound
Levobunolol Hydrochloride; 1(2H)-Naphthalenone, 5-[(2S)-3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]-3,4-dihydro-, hydrochloride (1:1); 1(2H)-Naphthalenone, 5-[(2S)-3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]-3,4-dihydro-, hydrochloride (9CI); 1(2H)-Naphthalenone, 5-[3-(tert-butylamino)-2-hydroxypropoxy]-3,4-dihydro-, hydrochloride, (-)- (8CI); 1(2H)-Naphthalenone, 5-[3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]-3,4-dihydro-, hydrochloride, (S)-; AG 901; Betagan; Gotensin; Levobunolol hydrochloride; Vitagan; W 7000A; l-Bunolol hydrochloride
CAS Registry Number
27912-14-7
Primary record
Levobunolol Hydrochloride; 1(2H)-Naphthalenone, 5-[(2S)-3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]-3,4-dihydro-, hydrochloride (1:1); 1(2H)-Naphthalenone, 5-[(2S)-3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]-3,4-dihydro-, hydrochloride (9CI); 1(2H)-Naphthalenone, 5-[3-(tert-butylamino)-2-hydroxypropoxy]-3,4-dihydro-, hydrochloride, (-)- (8CI); 1(2H)-Naphthalenone, 5-[3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]-3,4-dihydro-, hydrochloride, (S)-; AG 901; Betagan; Gotensin; Levobunolol hydrochloride; Vitagan; W 7000A; l-Bunolol hydrochloride
- 库存
- 2,339 克
- 纯度
- 98.8 %
- CAS
- 27912-14-7
化合物标识与属性
- CAS
- 27912-14-7
- PubChem CID
- 5284409
- SMILES
- CC(C)(C)NC[C@@H](COC1=CC=CC2=C1CCCC2=O)O.Cl
- Canonical SMILES
- CC(C)(C)NC[C@H](O)COc1cccc2c1CCCC2=O.Cl
名称与同义词
- levobunolol hydrochloride
- Betagan
- Levobunolol HCl
- Akbeta
- Gotensin
- Vistagan
- Levobunolol.HCl
- l-Bunolol
- 27912-14-7
- Levobunolol (hydrochloride)
- Prestwick_167
- Betagan (TN)
- Bunolol hydrochloride
- l-Bunolol hydrochloride
- (-)-Bunolol
- Levobunolol, Hydrochloride
- RefChem:55472
- AC1NR4EJ
- C17H26ClNO3
- ent-Levobunolol,Hydrochloride
- O90S49LDHH
- (-) -Levobunolol hydrochloride
- DTXSID6020777
- DTXCID20777
- UNII-O90S49LDHH
- Levobunolol hydrochloride [USAN]
- levobunolol monohydrochloride
- CHEBI:6439
- W 7000A
- C17H25NO3.ClH
- C17H25NO3.HCl
- SCHEMBL42262
- MLS002154030
- (-)-Levobunolol hydrochloride
- DNTDOBSIBZKFCP-YDALLXLXSA-N
- orb1707079
- CHEMBL1201177
- NSC-759158
- CTK8G0556
- EINECS 248-725-3
- ERK5-2C08
- MSK10930A
- W-7000A
- C17-H25-N-O3.Cl-H
- GLXC-10189
- HMS1570J15
- HY-B1035
- Tox21_110617
- EBC-73231
- EX-A11140
- Levobunolol hydrochloride (JAN/USP)
- MFCD03425587
- W7000A
- LEVOBUNOLOL HYDROCHLORIDE [MI]
- Levobunolol hydrochloride [USAN:USP]
- AKOS030526127
- Tox21_110617_1
- CCG-220847
- CID5284409
- CS-4554
- LEVOBUNOLOL HYDROCHLORIDE [JAN]
- LS-7472
- W 6421A
- LEVOBUNOLOL HYDROCHLORIDE [MART.]
- LEVOBUNOLOL HYDROCHLORIDE [VANDF]
- NCGC00016801-01
- NCGC00016801-05
- AN-15275
- LEVOBUNOLOL HYDROCHLORIDE [USP-RS]
- LEVOBUNOLOL HYDROCHLORIDE [WHO-DD]
- MS-24904
- SMR001233357
- CAS-27912-14-7
- FT-0630538
- D01025
- F85217
- LEVOBUNOLOL HYDROCHLORIDE [ORANGE BOOK]
- LEVOBUNOLOL HYDROCHLORIDE [USP MONOGRAPH]
- A1024942
- (-)-3,4-Dihydro-5-(3-(tert-butylamino)-2-hydroxypropoxy)-1(2H)-naphthalenone hydrochloride
- Q27107207
- (-)-5-(3-(tert-Butylamino)-2-hydroxypropoxy)-3,4-dihydro-1(2H)-naphthalenone hydrochloride
- 5-[(2S)-3-(tert-butylamino)-2-hydroxypropoxy]-3,4-dihydro-2H-naphthalen-1-one hydrochloride
- 47141-42-4
- 5-({(2S)-3-[(1,1-dimethylethyl)amino]-2-hydroxypropyl}oxy)-3,4-dihydronaphthalen-1(2H)-one hydrochloride
- 5-[(2S)-3-(tert-butylamino)-2-hydroxy-propoxy]tetralin-1-one hydrochloride
- (S)-5-[3-[(1,1-Dimethylethyl)amino]-2-hydroxypropoxy]-3,4-dihydro-1(2H)-naphthalenone
- 5-[(2R)-3-(tert-butylamino)-2-hydroxypropoxy]-3,4-dihydro-2H-naphthalen-1-one
- 5-[(2S)-3-[(1,1-Dimethylethyl)amino]-2-hydroxypropoxy]-3,4-dihydro-1(2H)-naphthalenone
- 5-{[3-(tert-butylamino)-2-hydroxypropyl]oxy}-3,4-dihydronaphthalen-1(2H)-one hydrochloride
- tert-butyl-[(2S)-2-hydroxy-3-(1-oxotetralin-5-yl)oxy-propyl]ammonium;chloride
- (-)-(S)-5-(3-(TERT-BUTYLAMINO)-2-HYDROXYPROPOXY)-3,4-DIHYDRO-1(2H)-NAPHTHALENONE HYDROCHLORIDE
- (-)-5-(3-(tert-Butylamino)-2-hydroxypropoxy)-3,4-dihydronaphthalene-1(2H)-one hydrochloride
- (-)-5-[3-(tert-butylamino)-2-hydroxypropoxy]-3,4-dihydronaphthalene-1(2H)-one hydrochloride
- (2S)-N-(tert-butyl)-2-hydroxy-3-[(5-oxo-5,6,7,8-tetrahydronaphthalen-1-yl)oxy]propan-1-aminium chloride
- 1(2H)-Naphthalenone, 3,4-dihydro-5-(3-(tert-butylamino)-2-hydroxypropoxy)-, hydrochloride, (-)-
- 1(2H)-Naphthalenone, 3,4-dihydro-5-(3-(tert-butylamino)-2-hydroxypropoxy)-, hydrochloride,(-)-
- 1(2H)-Naphthalenone, 5-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-, hydrochloride, (-)-
- 1(2H)-NAPHTHALENONE, 5-(3-((1,1-DIMETHYLETHYL)AMINO)-2-HYDROXYPROPOXY)-3,4-DIHYDRO-, HYDROCHLORIDE, (-)-(S)
- 1(2H)-Naphthalenone, 5-[(2S)-3-[(1,1-dimethylethyl) amino]-2-hydroxypropoxy]-3,4-dihydro-, hydrochloride
- 248-725-3
- 27867-05-6
- 5-[(2S)-3-(tert-butylamino)-2-hydroxypropoxy]-3,4-dihydro-2H-naphthalen-1-one;hydrochloride
- 5-[(2S)-3-(tert-butylamino)-2-hydroxypropoxy]-3,4-dihydronaphthalen-1(2H)-one hydrochloride
- 5-[(2S)-3-(tert-Butylamino)-2-hydroxypropoxy]-3,4-dihydronaphthalen-1(2H)-one--hydrogen chloride (1/1)
- Levobunolol Hydrochloride; 1(2H)-Naphthalenone, 5-[(2S)-3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]-3,4-dihydro-, hydrochloride (1:1); 1(2H)-Naphthalenone, 5-[(2S)-3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]-3,4-dihydro-, hydrochloride (9CI); 1(2H)-Naphthalenone, 5-[3-(tert-butylamino)-2-hydroxypropoxy]-3,4-dihydro-, hydrochloride, (-)- (8CI); 1(2H)-Naphthalenone, 5-[3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]-3,4-dihydro-, hydrochloride, (S)-; AG 901; Betagan; Gotensin; Levobunolol hydrochloride; Vitagan; W 7000A; l-Bunolol hydrochloride